Skip to main content
Premium Trial:

Request an Annual Quote

Roche to Invest $1.6M in Diabetes Biomarker-Discovery Research with SystemsX

NEW YORK, Dec. 14 (GenomeWeb News) - Roche announced yesterday a three-year research partnership with SystemsX, the Swiss Initiative in Systems Biology, to develop diabetes drugs and identify biomarkers.

 

Roche will finance 2.1 million Swiss francs ($1.6 million) for the duration of the project.

 

In a statement, Roche called the project a "holistic" approach.

 

A team of 15 scientists from Roche and SystemsX's Competence Center for Systems Physiology and Metabolic Diseases will be joined by researchers from the Swiss Federal Institute of Technology in Zurich and University of Zurich.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.